相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PTEN Loss Mediates Clinical Cross-Resistance to CDK4/6 and PI3Kα Inhibitors in Breast Cancer
Carlotta Costa et al.
CANCER DISCOVERY (2020)
Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future
Laura M Spring et al.
LANCET (2020)
Fulvestrant in the treatment of hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: A review
Junjie Li et al.
CANCER MEDICINE (2019)
Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial
Lorenzo Rossi et al.
BREAST CANCER RESEARCH (2019)
CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials
Carlo Messina et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
The use of high-dose estrogens for the treatment of breast cancer
Herjan J. T. Coelingh Bennink et al.
MATURITAS (2017)
Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer
Rui Xiong et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
A phase II trial of low-dose estradiol in postmenopausal women with advanced breast cancer and acquired resistance to aromatase inhibition
G. Zucchini et al.
EUROPEAN JOURNAL OF CANCER (2015)
Menopausal Hormone Therapy Influence on Breast Cancer Outcomes in the Women's Health Initiative
Rowan T. Chlebowski et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)
Empirical and Semi-Mechanistic Modelling of Double-Peaked Pharmacokinetic Profile Phenomenon Due to Gastric Emptying
Kayode Ogungbenro et al.
AAPS JOURNAL (2015)
The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer
V. Craig Jordan
ENDOCRINE-RELATED CANCER (2015)
Novel Selective Estrogen Mimics for the Treatment of Tamoxifen-Resistant Breast Cancer
Mary Ellen Molloy et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Protein Kinase C beta in the tumor microenv ronment promotes mammary tumorigenesis
Julie A. Wallace et al.
FRONTIERS IN ONCOLOGY (2014)
PKC alpha and ER beta Are Associated with Triple-Negative Breast Cancers in African American and Caucasian Patients
Debra A. Tonetti et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2012)
Multiple Peaking Phenomena in Pharmacokinetic Disposition
Neal M. Davies et al.
CLINICAL PHARMACOKINETICS (2010)
PKCα expression is a marker for breast cancer aggressiveness
Gry Kalstad Lonne et al.
MOLECULAR CANCER (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Lower-Dose vs High-Dose Oral Estradiol Therapy of Hormone Receptor-Positive, Aromatase Inhibitor-Resistant Advanced Breast Cancer A Phase 2 Randomized Study
Matthew J. Ellis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
The Human Protein Atlas - a tool for pathology
F. Ponten et al.
JOURNAL OF PATHOLOGY (2008)
Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer
J. W. Assender et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Overexpression of PKCα is required to impart estradiol inhibition and tamoxifen-resistance in a T47D human breast cancer tumor model
Xin Lin et al.
CARCINOGENESIS (2006)
Protein kinase C: a target for anticancer drugs?
HJ Mackay et al.
ENDOCRINE-RELATED CANCER (2003)
Elevated protein kinase C alpha expression may be predictive of tamoxifen treatment failure
DA Tonetti et al.
BRITISH JOURNAL OF CANCER (2003)
Enterohepatic circulation - Physiological, pharmacokinetic and clinical implications
MS Roberts et al.
CLINICAL PHARMACOKINETICS (2002)
分享论文
